Michiki Narushima

Title: Michiki Narushima: Innovator in Insulin-Producing Cell Lines

Introduction

Michiki Narushima is a notable inventor based in Okayama, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of insulin-producing cell lines. His innovative work has the potential to impact diabetes treatment and research.

Latest Patents

Narushima holds a patent for an "Insulin expressing human pancreatic islet cell line capable of reversibly proliferating and use thereof." This patent describes a reversibly immortalized human pancreatic islet cell line that contains an hTERT gene and an SV40T gene, each interposed between a pair of LoxP sequences. The cell line is characterized by its ability to produce insulin and enhance insulin expression after the excision of the hTERT and SV40T genes. This invention allows for the easy and reliable production of insulin-producing cells to meet demand. The patent was deposited with the International Patent Organism Depository at the National Institute of Advanced Industrial Science and Technology in Japan on September 4, 2003, with the accession number FERM BP-08461.

Career Highlights

Throughout his career, Narushima has worked with various organizations, including Kuraray Medical Inc. His work has focused on advancing the understanding and application of pancreatic islet cells in medical science.

Collaborations

Narushima has collaborated with notable colleagues such as Yoshihito Tanaka and Naoya Kobayashi. Their combined efforts have contributed to the advancements in the field of insulin-producing cell lines.

Conclusion

Michiki Narushima's innovative work in developing insulin-producing cell lines represents a significant advancement in biotechnology. His contributions have the potential to enhance diabetes treatment and improve the quality of life for many individuals.